Searched for
JANSSEN UNIT
Biocon Biologics gets US nod to launch Stelara biosimilarBiocon Biologics has secured USFDA approval to launch the biosimilar of Janssen's Stelara by February 2025, targeting autoimmune conditions...- Biocon settles with Janssen to commercialise biosimilar products in Europe, Canada, JapanBiocon Biologics has entered into a settlement and licence agreement with Janssen Biotech Inc, Janssen Sciences Ireland, and Johnson & John...
- Stocks in news: Suven Pharma, MOIL, Adani stocks, ICICI Lombard, VedantaSuven Pharmaceuticals and Cohance Lifesciences signed a definitive agreement to merge their businesses, which will further strengthen the f...
- Biocon Biologics inks licence pact with Janssen for biosimilar productThe agreement licenses the company to launch in the US in February 2025, once approved by the US Food and Drug Administration(USFDA), Bioco...
- GlaxoSmithKline Pharma names Bhushan Akshikar as new Managing DirectorBefore joining GSK, Akshikar spent 15 years with Janssen, Johnson & Johnson in various roles leading both specialty and primary care busine...
- USIBC appoints four new members to its India Advisory CouncilArundhati Bhattacharya, Chief Executive Officer and Chairperson, Salesforce India who has assumed the role of IAC Chair said the council pl...
- J&J seeks DCGI's permission for phase-3 clinical trial of its single-dose Covid-19 vaccine“We have submitted an application to the Drugs Controller General of India (DCGI) requesting approval to conduct a bridging clinical study ...
- EU reviews Johnson & Johnson COVID-19 vaccine for blood clots, expands AstraZeneca probeFour serious cases of rare blood clots with low platelets, one of which was fatal, have been reported after inoculation with J&J's vaccine ...
- Johnson & Johnson testing vaccine on teensJ&J says the first teens are being enrolled in the United Kingdom and Spain. Teens in the United States, Canada and the Netherlands will be...
- Waive bridging trials for fast vaccine rollout: ExpertsIn a “pandemic situation, credible evidence examined by reliable regulatory agencies in other countries may be accepted to fast-track appro...
- Johnson & Johnson requests emergency authorization for Covid vaccineJ&J subsidiary Janssen Biotech "has submitted an application to the US Food and Drug Administration (FDA) requesting Emergency Use Authoriz...
- J&J enrolls about 45,000 participants for late-stage COVID-19 vaccine trialJ&J also said it plans to submit an emergency use authorization application to the U.S. Food and Drug Administration (FDA) in February if t...
- J&J to start mid-stage coronavirus vaccine trials in 3 European countries next weekSpain, which has western Europe's highest tally of coronavirus cases, is also working with AstraZeneca via the European Union's vaccine pro...
- Unichem Labs gets USFDA nod to market muscle spasm tabletsThe company has received abbreviated new drug application (ANDA) approval to market its Cyclobenzaprine Hydrochloride tablets USP 5 mg, 7.5...
- Glenmark Pharma gets USFDA nod for prostate cancer treatment drugShares of Glenmark Pharma were trading 0.15 per cent higher at Rs 286.00 apiece on the BSE.
- Lupin launches Ortho-Cyclen tablets in USLupin said, "It has launched its Norgestimate and Ethinyl Estradiol tablets USP, 0.25 mg/0.035 mg having received approval from US FDA earl...
- Lupin gets USFDA nod for HIV drugDrug firm Lupin has received tentative approval from the US health regulator to market a generic version of Prezista tablets, used in treat...
- New system uses Sun to make sea water potableA new "ground-breaking" prototype system that turns sea water into drinking water using just the power of the Sun has been successfully tes...
- Aurobindo gets USFDA nod for generic Levofloxacin injectionAurobindo now has a total of 175 abbreviated new drug (ANDA) approvals from the USFDA, the company said.
- Genmab inks $1.1 bn deal with Johnson & JohnsonDanish pharma firm Genmab has said that it had reached a deal worth up to $1.1 bn with US drug giant Johnson & Johnson.
Load More
